Q59961 (PARE_STRPN) Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)

DNA topoisomerase 4 subunit B UniProtKBInterProInteractive Modelling

647 aa; Sequence (Fasta) ; 1 identical sequence: Streptococcus pneumoniae: Q3HZ66

Available Structures

19 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
A low-resolution three-gate structure of topoisomerase IV from Streptococcus pneumoniae in space gr… Heteromer
P72525;
24-640
MG;LFX;
Assess
Quinolone(Levofloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae Heteromer
P72525;
414-640
MG;LFX;
Assess
Quinolone(Clinafloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae Heteromer
P72525;
414-640
MG;NFX;
Assess
Detailed structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases Heteromer
P72525;
415-640
MG;LFX;
Assess
Quinolone(Trovafloxacin)-DNA cleavage complex of type IV topoisomerase from S. pneumoniae Heteromer
P72525;
415-640
MG;TR6;
Assess
Inhibitor-stabilized topoisomerase IV-DNA cleavage complex (S. pneumoniae) Heteromer
P72525;
415-640
MG;PDQ;
Assess
Quinazolinedione-DNA cleavage complex of type IV topoisomerase from S. pneumoniae Heteromer
P72525;
415-640
MG;PDQ;
Assess
Novel fluoroquinolones in complex with topoisomerase IV from S. pneumoniae and E-site G-gate Heteromer
P72525;
415-640
MG;1UV;
Assess
Detailed structural insight into the DNA cleavage complex of type IIA topoisomerases (cleaved form) Heteromer
P72525;
415-640
MG;
Assess
Novel fluoroquinolones in complex with topoisomerase IV from S. pneumoniae and E-site G-gate Heteromer
P72525;
415-640
MG;AF5;
Assess
Detailed structural insight into the DNA cleavage complex of type IIA topoisomerases (re-sealed for… Heteromer
P72525;
415-640
MG;
Assess
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases Heteromer
P72525;
417-636
MFX;
Assess
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases Heteromer
P72525;
417-636
NFX;
Assess
A three-gate structure of topoisomerase IV from Streptococcus pneumoniaehomo-2-mer20-647
MG;
Assess
AMP-PNP-stabilized ATPase domain of topoisomerase IV from Streptococcus pneumoniae, complex type Ihomo-2-mer4-400
ANP;NA;MG;
Assess
AMP-PNP-stabilized ATPase domain of topoisomerase IV from Streptococcus pneumoniae, complex type IIhomo-2-mer5-400
ANP;MG;
Assess
Quinazolinedione(PD 0305970)-DNA cleavage complex of topoisomerase IV from S. pneumoniaehomo-2-mer415-643
MG;PDQ;
Assess
Quinolone(Trovafloxacin)-DNA cleavage complex of topoisomerase IV from S. pneumoniaehomo-2-mer415-643
MG;TR6;
Assess
Quinolone(Moxifloxacin)-DNA cleavage complex of topoisomerase IV from S. pneumoniaehomo-2-mer415-643
MG;MFX;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5j5p.1.Amonomer0.814-400
MG;99.75
Assess
4i3h.1.Cmonomer0.7824-642
99.54
Assess
6gav.1.Amonomer0.7524-640
49.44
Assess